Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Planning for retirement now can significantly enhance your financial security. Learn the reasons to prioritize your retirement planning today.
27,829 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
The AI boom has drawn big names into the stock market arena. This article breaks down what billionaire Stanley Drucke...
Two pharma giants compete for your portfolio's income. This guide weighs yields, safety, and long-term risks to answe...
A dramatic seed-phrase leak led to a flurry of activity around seized wallets. This piece explores what happened, why...
Roku stock jumped Friday on chatter of a potential sale, but the real action could come from a June 22 event investor...
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
ASML’s price sits near the $1,800 mark, sparking questions about a possible stock split. This guide explains what a s...
A routine check request at a local credit union led to an account freeze and a wider fraud investigation. This articl...
A leading wealth manager recently moved a sizable stake in a global asset manager. This decision signals confidence i...
A hypothetical look at britain's warren buffett pared nearly every position in a $13 billion portfolio during the fir...
A major fund recently sold its entire NIO position for about $79.8 million. This article breaks down what happened, w...
Choosing the right investing platform can save time and money. This guide shows how to pick tools that align with you...